COColin S. Osborne

Colin S. Osborne

*This is an algorithmically generated author record based on publicly available information.

Colin S. Osborne has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Amino Acid Substitution inTrichophyton rubrumSqualene Epoxidase Associated with Resistance to Terbinafine

    by Colin S. Osborne, Ingrid Leitner, Bertrand Favre, Neil S. Ryder

    There has only been one clinically confirmed case of terbinafine resistance in dermatophytes, where six sequentialTrichophyton rubrumisolates from the same patient were found to be resistant to terbinafine and cross-resistant to other squalene epoxidase (SE) inhibitors. Microsomal SE activity from these resistant isolates was insensitive to terbinafine, suggesting a target-based mechanism of resistance (B. Favre, M. Ghannoum, and N. S. Ryder, Med. Mycol. 42:525-529, 2004). In this study, we have characterized at the molecular level the cause of the resistant phenotype of these clinical isolates. Cloning and sequencing of the SE gene and cDNA fromT. rubrumrevealed the presence of an intron in the gene and an open reading frame encoding a protein of 489 residues, with an equivalent similarity (57%) to both yeast and mammalian SEs. The nucleotide sequences of SE from two terbinafine-susceptible strains were identical whereas those of terbinafine-resistant strains, serially isolated from the same patient, each contained the same single missense introducing the amino acid substitution L393F. Introduction of the corresponding substitution in theCandida albicansSE gene (L398F) and expression of this gene inSaccharomyces cerevisiaeconferred a resistant phenotype to the transformants when compared to those expressing the wild-type sequence. Terbinafine resistance in theseT. rubrumclinical isolates appears to be due to a single amino acid substitution in SE.


  • Open Access

    Antifungal drug response in anin vitromodel of dermatophyte nail infection

    by C. S. Osborne, I. Leitner, B. Favre, N. S. Ryder

    Despite terbinafine being fungicidal against Trichophyton rubrum in standard NCCLS assays and rapidly accumulating in nails in vivo, onychomycosis patients require prolonged terbinafine treatment to be cured. To investigate this, we developed a more clinically relevant onychomycosis in vitro test model. Human nail powder inoculated with T. rubrum and incubated in liquid RPMI 1640 salt medium, which did not support growth alone, developed extensive and invasive mycelial growth. Antifungal drugs were added at different concentrations and cultures incubated for 1 to 4 weeks. Fungal survival was determined by spreading cultures on PDA plates without drug and measuring CFU after 1 to 4 weeks incubation. Drug activity was expressed as the nail minimum fungicidal concentration (Nail-MFC) required for 99.9% elimination of viable fungus. Terbinafine Nail-MFC was 4 µg/ml after 1 week exposure, decreasing to 1 µg/ml after 4 weeks exposure, much higher than MFCs ≤ 0.03 µg/ml determined in standard NCCLS MIC assays. In contrast, other clinically used drugs were unable to kill T. rubrum after 4 weeks incubation in this model. Invasive mycelial growth on nail appears to protect T. rubrum from the cidal action of systemic drugs, thus providing a rationale for the long treatment periods in onychomycosis.


  • In Vitro Analysis of the Ability of Trichophyton rubrum To Become Resistant to Terbinafine

    by Colin S. Osborne, Bettina Hofbauer, Bertrand Favre, Neil S. Ryder

    In this study, we have investigated in vitro the resistance frequency and development of resistance to terbinafine of Trichophyton rubrum. Results demonstrated that naturally occurring mutants are rare and that T. rubrum appears to have little capacity to develop resistance to terbinafine even after prolonged exposure.